Ad is loading...
EIPIX
Price
$19.08
Change
+$0.18 (+0.95%)
Updated
Nov 15 closing price
SMRPX
Price
$10.38
Change
-$0.01 (-0.10%)
Updated
Nov 15 closing price
Ad is loading...

EIPIX vs SMRPX

Header iconEIPIX vs SMRPX Comparison
Open Charts EIPIX vs SMRPXBanner chart's image
EIP Growth and Income I
Price$19.08
Change+$0.18 (+0.95%)
VolumeN/A
CapitalizationN/A
Westwood Salient MLP & Engy Infras Ultr
Price$10.38
Change-$0.01 (-0.10%)
VolumeN/A
CapitalizationN/A
EIPIX vs SMRPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EIPIX vs. SMRPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIPIX is a Buy and SMRPX is a StrongBuy.

FUNDAMENTALS
Fundamentals
SMRPX has more cash in the bank: 1.22B vs. EIPIX (79.4M). SMRPX pays higher dividends than EIPIX: SMRPX (5.72) vs EIPIX (3.71). EIPIX was incepted earlier than SMRPX: EIPIX (18 years) vs SMRPX (9 years). EIPIX (1000000) and SMRPX (1000000) have matching initial minimum investment requirements. SMRPX annual gain was more profitable for investors over the last year : 45.97 vs. EIPIX (34.40). SMRPX return over 5 years is better than : 103.69 vs. EIPIX (56.63).
EIPIXSMRPXEIPIX / SMRPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD30.46539.45177%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets79.4M1.22B6%
Annual Yield % from dividends3.715.7265%
Returns for 1 year34.4045.9775%
Returns for 3 years36.5372.7150%
Returns for 5 years56.63103.6955%
Returns for 10 years43.67N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFSH0.520.04
+8.76%
1847 Holdings LLC
CCAP18.98-0.15
-0.78%
Crescent Capital BDC
BLTE82.81-0.85
-1.02%
Belite Bio
RRX169.73-2.76
-1.60%
Regal Rexnord Corp
RPTX3.11-0.14
-4.31%
Repare Therapeutics